Claritas Rx, the patient journey experts, today announced it has won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category. The award recognizes Patient Watchtower™ and the Patient Services Omnichannel CRM — two connected AI-powered solutions that let biopharma manufacturers spot risk earlier in the patient journey and coordinate real-time action across every partner helping patients start and stay on therapy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902095459/en/
Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy. Patient Watchtower™ and Patient Services Omnichannel CRM recognized for turning predictive signals into coordinated action across the patient journey.
For patients prescribed specialty and rare disease therapies, the path from prescription to treatment is fragile. Between 31% and 40% of specialty prescriptions go unfilled, and patients whose fill takes longer than 30 days convert at a rate 18 percentage points lower than those who fill sooner. Along the way, a single patient may touch a hub, a specialty pharmacy, a payer, and a copay program within days of each other, each generating data that, on its own, tells only part of the story. Historically, patient services teams have had to wait for a missed fill or a lapsed authorization to signal that a patient had already fallen off therapy.
Patient Watchtower and the Patient Services Omnichannel CRM close that gap by connecting prediction to action at every stage of the journey. Patient Watchtower uses AI and machine learning to predict therapy discontinuation, prior authorization denial, and prescription abandonment up to 90 days in advance, with up to 80% precision. The moment a patient is flagged, the Patient Services Omnichannel CRM helps turns that signal into coordinated outreach, connecting case managers, hub partners, and specialty pharmacies in a single workflow so the right partner can respond before a patient drops off therapy.
“Every stage of the patient journey generates a signal, but most teams don’t see it until it’s too late,” said Michael Fitzgibbons, CEO of Claritas Rx. “This award reflects work that’s built entirely around closing that gap — connecting the moment we detect risk to the moment someone acts on it, so patients start and stay on the therapies they need. That’s the promise we make on every patient journey, and it’s an honor to see our innovation recognized by Fierce and the industry.”
Since launching, Patient Watchtower and the Patient Services Omnichannel CRM have delivered measurable results across the patient journey, including a 20% improvement in fill rates, 17% increase in refill rates, a 98% partner response rate within 24 hours, and a significant reduction in manual case management burden — freeing patient services teams to focus on direct patient care rather than administrative reconciliation.
The Fierce AI Innovation Awards, presented by Fierce Life Sciences, recognize organizations that are moving beyond AI pilots to deliver measurable impact across the biotech, pharma, and healthcare value chain, from R&D and clinical trials to commercialization, manufacturing, and care delivery. Entries were evaluated on innovation, impact, execution, scalability, and industry relevance. Winners were announced in Fierce Life Sciences’ September 2 Special Report.
About Claritas Rx
Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260902095459/en/
Media gallery
